Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohty

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Leukemia|October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie CellulaireM Mohty, M Labopin, M L Balère, et al.
Bone Marrow Transplantation|January 31, 2017
Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adultsY Le Bris, T Guillaume, A Ménard, et al.
Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.
Bone Marrow Transplantation|March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015A Sureda, P Bader, S Cesaro, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2015
Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipientsA Ruggeri, G Roth-Guepin, G Battipaglia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 8, 2012
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)A Xhaard, F Lanternier, R Porcher, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Bone Marrow Transplantation|November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationK Hübel, M M Fresen, J F Apperley, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Leukemia|October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie CellulaireM Mohty, M Labopin, M L Balère, et al.
Bone Marrow Transplantation|January 31, 2017
Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adultsY Le Bris, T Guillaume, A Ménard, et al.
Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.
Bone Marrow Transplantation|March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015A Sureda, P Bader, S Cesaro, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2015
Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipientsA Ruggeri, G Roth-Guepin, G Battipaglia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 8, 2012
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)A Xhaard, F Lanternier, R Porcher, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Bone Marrow Transplantation|November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationK Hübel, M M Fresen, J F Apperley, et al.
Pageof 18